First-in-human study of inhaled Azacitidine in patients with advanced non-small cell lung cancer.

MLA

Cheng, Haiying, et al. “First-in-Human Study of Inhaled Azacitidine in Patients with Advanced Non-Small Cell Lung Cancer.” Lung Cancer (Amsterdam, Netherlands), vol. 154, Apr. 2021, pp. 99–104. EBSCOhost, https://doi.org/10.1016/j.lungcan.2021.02.015.

APA

Cheng, H., Zou, Y., Shah, C. D., Fan, N., Bhagat, T. D., Gucalp, R., Kim, M., Verma, A., Piperdi, B., Spivack, S. D., Halmos, B., & Perez-Soler, R. (2021). First-in-human study of inhaled Azacitidine in patients with advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands), 154, 99–104. https://doi.org/10.1016/j.lungcan.2021.02.015

Chicago

Cheng, Haiying, Yiyu Zou, Chirag D Shah, Ni Fan, Tushar D Bhagat, Rasim Gucalp, Mimi Kim, et al. 2021. “First-in-Human Study of Inhaled Azacitidine in Patients with Advanced Non-Small Cell Lung Cancer.” Lung Cancer (Amsterdam, Netherlands) 154 (April): 99–104. doi:10.1016/j.lungcan.2021.02.015.